Scinovex
review Open AccessTop 1% cited

RNA-based therapeutics: an overview and prospectus

Cell Death and Disease · 2022 · Vol. 13(7) · pp. 644–644
Yiran ZhuLiyuan ZhuXian WangHongchuan Jin

Abstract

The growing understanding of RNA functions and their crucial roles in diseases promotes the application of various RNAs to selectively function on hitherto "undruggable" proteins, transcripts and genes, thus potentially broadening the therapeutic targets. Several RNA-based medications have been approved for clinical use, while others are still under investigation or preclinical trials. Various techniques have been explored to promote RNA intracellular trafficking and metabolic stability, despite significant challenges in developing RNA-based therapeutics. In this review, the mechanisms of action, challenges, solutions, and clinical application of RNA-based therapeutics have been comprehensively summarized.

RNA Interference and Gene DeliveryRNA Research and SplicingRNA modifications and cancerRNAComputational biologyBiologyFunction (biology)ProspectusBioinformaticsGeneCell biologyGenetics

MeSH terms

RNA InterferenceRNA, Small Interfering

Funding

  • National Natural Science Foundation of China
Citations
566
FWCI
45.84
field-weighted impact
References
172
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.